Analysis of polymorphisms in the SRD5A2 gene and semen parameters in Estonian men

Journal of Andrology

Volumn 31, Issue 4, 2010, Pages 372-378

  Peters, Maire ^a,b   Saare, Merli ^a   Kaart, Tanel ^c   Haller Kikkatalo, Kadri ^a   Lend, Ave Kris ^a   Punab, Margus ^d   Metspalu, Andres ^a,b   Salumets, Andres ^a,e  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c ESTONIAN UNIVERSITY OF LIFE SCIENCES   (Estonia)

^d TARTU UNIVERSITY HOSPITAL   (Estonia)

^e Competence Centre on Reproductive Medicine and Biology ^*  (Estonia)

Author keywords

Male infertility; Sperm motility; Testicular volume; V89L

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FOLLITROPIN; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE 2; TESTOSTERONE;

ADULT; ALLELE; ARTICLE; AZOOSPERMIA; CONTROLLED STUDY; DNA POLYMORPHISM; ESTONIA; FOLLITROPIN BLOOD LEVEL; GENETIC ANALYSIS; GENOTYPE; HOMOZYGOTE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OLIGOSPERMIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOZOON; SPERMATOZOON DENSITY; TESTOSTERONE BLOOD LEVEL;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; ADOLESCENT; ADULT; AZOOSPERMIA; CASE-CONTROL STUDIES; ESTONIA; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE PROTEINS; OLIGOSPERMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; SEMEN ANALYSIS; YOUNG ADULT;

EID: 77957845939     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.109.008714     Document Type: Article

References (48)

1. Aljanabi SM, Martinez I. Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Res. 1997;25:4692-4693. (Pubitemid 27500787)
2. Allen NE, Forrest MS, Key TJ. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. Cancer Epidemiol Biomarkers Prev. 2001;10:185-189.
3. Amory JK, Wang C, Swerdloff RS, Anawalt BD, Matsumoto AM, Bremner WJ, Walker SE, Haberer LJ, Clark RV. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab. 2007;92:1659-1665. (Pubitemid 46997168)
4. Anderson RA, Kelly RW, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone. J Androl. 1997;18:366-371.
5. Anderson RA, Wallace AM, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. J Clin Endocrinol Metab. 1996;81:902-908.
6. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265. (Pubitemid 40202029)
7. Berthaut I, Mestayer C, Portois MC, Cussenot O, Mowszowicz I. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture. Prostate. 1997;32:155-163. (Pubitemid 27337949)
8. Cai LQ, Fratianni CM, Gautier T, Imperato-McGinley J. Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency. J Clin Endocrinol Metab. 1994;79:409-414. (Pubitemid 24256527)
9. Can S, Zhu YS, Cai LQ, Ling Q, Katz MD, Akgun S, Shackleton CH, Imperato-McGinley J. The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. J Clin Endocrinol Metab. 1998;83:560-569. (Pubitemid 28496540)
10. Chavez B, Valdez E, Vilchis F. Uniparental disomy in steroid 5alpha-reductase 2 deficiency. J Clin Endocrinol Metab. 2000;85:3147-3150.
11. Cornwall GA. New insights into epididymal biology and function. Hum Reprod Update. 2009;15:213-227.
12. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217-1223.
13. Eicheler W, Tuohimaa P, Vilja P, Adermann K, Forssmann WG, Aumuller G. Immunocytochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J Histochem Cytochem. 1994;42:667-675. (Pubitemid 24125755)
14. Elzanaty S, Giwercman YL, Giwercman A. Significant impact of 5alpha-reductase type 2 polymorphisms on sperm concentration and motility. Int J Androl. 2006;29:414-420. (Pubitemid 43736303)
15. Febbo PG, Kantoff PW, Platz EA, Casey D, Batter S, Giovannucci E, Hennekens CH, Stampfer MJ. The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer. Cancer Res. 1999;59:5878-5881. (Pubitemid 30004943)
16. Fernandez-Cancio M, Nistal M, Gracia R, Molina MA, Tovar JA, Esteban C, Carrascosa A, Audi L. Compound heterozygous mutations in the SRD5A2 gene exon 4 in a male pseudohermaphrodite patient of Chinese origin. J Androl. 2004;25:412-416. (Pubitemid 38509240)
17. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human genome. Science. 2002;296:2225-2229. (Pubitemid 34680308)
18. Giwercman YL, Abrahamsson PA, Giwercman A, Gadaleanu V, Ahlgren G. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population. Eur Urol. 2005;48:679-685. (Pubitemid 41278596)
19. Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer. 2007;120:776-780. (Pubitemid 46175396)
20. Henderson NA, Robaire B. Effects of PNU157706, a dual 5alpha-reductase inhibitor, on rat epididymal sperm maturation and fertility. Biol Reprod. 2005;72:436-443. (Pubitemid 40129720)
21. Hines RS, Tho SP, Behzadian MA, McDonough PG. Steroid 5alpha-reductase 2 gene melting polymorphisms in male subjects with azoospermia or oligospermia. Am J Obstet Gynecol. 1999;180:1394-1398.
22. Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol. 2002;198:51-59. (Pubitemid 36169934)
23. Jenkins EP, Hsieh CL, Milatovich A, Normington K, Berman DM, Francke U, Russell DW. Characterization and chromosomal mapping of a human steroid 5 alpha-reductase gene and pseudogene and mapping of the mouse homologue. Genomics. 1991;11:1102-1112.
24. Jensen TK, Jorgensen N, Punab M, Haugen TB, Suominen J, Zilaitiene B, Horte A, Andersen AG, Carlsen E, Magnus O, Matulevicius V, Nermoen I, Vierula M, Keiding N, Toppari J, Skakkebaek NE. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am J Epidemiol. 2004;159:49-58. (Pubitemid 38049421)
25. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA. Haplotype tagging for the identification of common disease genes. Nat Genet. 2001;29:233-237. (Pubitemid 32952665)
26. Labrie F, Sugimoto Y, Luu-The V, Simard J, Lachance Y, Bachvarov D, Leblanc G, Durocher F, Paquet N. Structure of human type II 5 alpha-reductase gene. Endocrinology. 1992;131:1571-1573.
27. Levine AC, Wang JP, Ren M, Eliashvili E, Russell DW, Kirschenbaum A. Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate. J Clin Endocrinol Metab. 1996;81:384-389. (Pubitemid 26035048)
28. Lindstrom S, Adami HO, Balter KA, Xu J, Zheng SL, Stattin P, Gronberg H, Wiklund F. Inherited variation in hormone-regulating genes and prostate cancer survival. Clin Cancer Res. 2007;13:5156-5161. (Pubitemid 47502084)
29. Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D, Cicek M, Love B, Bivolarevic V, Yang Q, Jiang Y, Hanzel DK, Dains K, Paris PL, Casey G, Witte JS. Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2. Eur J Hum Genet. 2004;12:321-332. (Pubitemid 38519346)
30. Mahony MC, Swanlund DJ, Billeter M, Roberts KP, Pryor JL. Regional distribution of 5alpha-reductase type 1 and type 2 mRNA along the human epididymis. Fertil Steril. 1998;69:1116-1121. (Pubitemid 28274903)
31. Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE, Reichardt JK. A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res. 1997;57:1020-1022. (Pubitemid 27138592)
32. Makridakis NM, di Salle E, Reichardt JK. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics. 2000;10:407-413.
33. Mazen I, Gad YZ, Hafez M, Sultan C, Lumbroso S. Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation. Clin Endocrinol (Oxf). 2003;58:627-631. (Pubitemid 36566806)
34. Montpetit A, Nelis M, Laflamme P, Magi R, Ke X, Remm M, Cardon L, Hudson TJ, Metspalu A. An evaluation of the performance of tag SNPs derived from HapMap in a Caucasian population. PLoS Genet. 2006;2:e27.
35. Ntais C, Polycarpou A, Ioannidis JP. SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2003;12:618-624. (Pubitemid 36899841)
36. Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol. 1999;162:1295-1300. (Pubitemid 29428566)
37. Payne AH, Kawano A, Jaffe RB. Formation of dihydrotestosterone and other 5 alpha-reduced metabolites by isolated seminiferous tubules and suspension of interstitial cells in a human testis. J Clin Endocrinol Metab. 1973;37:448-453.
38. Pearce CL, Makridakis NM, Ross RK, Pike MC, Kolonel LN, Henderson BE, Reichardt JK. Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study. Cancer Epidemiol Biomarkers Prev. 2002;11:417-418.
39. Robaire B, Viger RS. Regulation of epididymal epithelial cell functions. Biol Reprod. 1995;52:226-236.
40. Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN, Henderson BE. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res. 1998;58:4497-4504. (Pubitemid 28480602)
41. Steers WD. 5alpha-reductase activity in the prostate. Urology. 2001;58:17-24.
42. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978-989. (Pubitemid 32289743)
43. Takihara H, Cosentino MJ, Sakatoku J, Cockett AT. Significance of testicular size measurement in andrology: II. Correlation of testicular size with testicular function. J Urol. 1987;137:416-419. (Pubitemid 17028268)
44. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest. 1992;90:799-809.
45. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest. 1993;92:903-910.
46. Vilchis F, Mendez JP, Canto P, Lieberman E, Chavez B. Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin Endocrinol. 2000;52:383-387. (Pubitemid 30169696)
47. World Health Organization (WHO). WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 1999.
48. Zhao M, Baker SD, Yan X, Zhao Y, Wright WW, Zirkin BR, Jarow JP. Simultaneous determination of steroid composition of human testicular fluid using liquid chromatography tandem mass spectrometry. Steroids. 2004;69:721-726. (Pubitemid 39576715)